Fermentalg SA (EPA:ALGAE)

Market Cap	52.03M +90.2%
Revenue (ttm)	13.38M +16.4%
Net Income	-9.44M
EPS	-0.09
Shares Out	89.71M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	139,321
Average Volume	384,776
Open	0.5530
Previous Close	0.5600
Day's Range	0.5520 - 0.5850
52-Week Range	0.4000 - 0.7300
Beta	1.06
RSI	60.19
Earnings Date	May 5, 2026

About Fermentalg

Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; and biobased raw materials for industry from their CO2 emissions. The company was incorporated in 2009 and is headquartered in Libourne, France.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2009
• Employees: 63
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALGAE

Financial Performance

In 2025, Fermentalg's revenue was 13.38 million, an increase of 16.41% compared to the previous year's 11.50 million. Losses were -9.44 million, -26.71% less than in 2024.